EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ocular Surface Alterations and Topical Antiglaucomatous Therapy: A Review

Alessandro G Actis, Teresa Rolle

The Open Ophthalmology Journal · 03.10.2014 · 8 (1) · 67-72

DOI: 10.2174/1874364101408010067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Ophthalmology Journal, erschienen am 03.10.2014. Verfasst von Alessandro G Actis und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Torino - Department of Surgical Sciences - Eye Clinic, Via Juvarra 19 - 10121 - Torino, Italy. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular Surface Disease (OSD) is prevalent among medically treated patients with glaucoma. This is basically related to three key-points: OSD and glaucoma are both prevalent in elderly and are common comorbidities in the same patient; the role of the active ingredient of the medical antiglaucomatous therapy; the role of the preservative agent of this medical therapy. Considering the actual state of literature we can state that the active glaucoma agent have a role in OSD, but the main cause seems to be the preservative agent, in particular referring to benzalkonium chloride, BAK. In the clinical evaluation of dry eye patients there is no actually established gold standard. Since the ocular surface injury not only causes dry eye, red eye, eye itching, photophobia and other discomforts, but also increases the risk of failure of glaucoma surgery in patients, it becomes fundamental a complete and good clinical evaluation of OSD (considering Schirmer’s test, tear breakup time, corneal and conjunctival staining) together with a good evaluation of patients’ quality of life (with validated questionnaires). Development of complex preparations, preservative-free and/or novel preservative preparations for glaucoma therapy could provide a promising approach in the prevention of ocular surface injuries.

Schlagwörter

Stichwörter der Autor:innen

Benzalkonium chloride (BAK)dry eyeglaucomaocular surface disease (OSD)quality of life (QoL).

Autor:innen und Institutionen

  • University of Torino - Department of Surgical Sciences - Eye Clinic, Via Juvarra 19 - 10121 - Torino, Italy.

Zitieren

APA

Actis, A. G., & Rolle, T. (2014). Ocular Surface Alterations and Topical Antiglaucomatous Therapy: A Review. The Open Ophthalmology Journal, 8(1), 67-72. https://doi.org/10.2174/1874364101408010067

Vancouver

Actis AG, Rolle T. Ocular Surface Alterations and Topical Antiglaucomatous Therapy: A Review. The Open Ophthalmology Journal. 2014;8(1):67-72. doi:10.2174/1874364101408010067

BibTeX
@article{Actis2014,
  author = {Actis, Alessandro G and Rolle, Teresa},
  title = {Ocular Surface Alterations and Topical Antiglaucomatous Therapy: A Review},
  journal = {The Open Ophthalmology Journal},
  year = {2014},
  volume = {8},
  number = {1},
  pages = {67--72},
  doi = {10.2174/1874364101408010067}
}
Kostenlos starten →